These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28740144)

  • 1. Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design.
    Sagar A; Haleem N; Bashir YM; Ashish
    Sci Rep; 2017 Jul; 7(1):6204. PubMed ID: 28740144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R; Blok A; Pannu NS; Ubbink M
    Biochemistry; 2019 Feb; 58(7):997-1009. PubMed ID: 30632739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structure of Phosphoserine BlaC from
    Moural TW; White DS; Choy CJ; Kang C; Berkman CE
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269656
    [No Abstract]   [Full Text] [Related]  

  • 4. Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb.
    White DS; Choy CJ; Moural TW; Martin SE; Wang J; Gargaro S; Kang C; Berkman CE
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2116-2118. PubMed ID: 31281019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F; Cassidy C; Sacchettini JC
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput fluorescent screening of β-lactamase inhibitors to improve antibiotic treatment strategies for tuberculosis.
    Yan F; He S; Han X; Wang J; Tian X; Wang C; James TD; Cui J; Ma X; Feng L
    Biosens Bioelectron; 2022 Nov; 216():114606. PubMed ID: 35952435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
    Tremblay LW; Fan F; Blanchard JS
    Biochemistry; 2010 May; 49(17):3766-73. PubMed ID: 20353175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
    Egesborg P; Carlettini H; Volpato JP; Doucet N
    Protein Sci; 2015 Apr; 24(4):534-44. PubMed ID: 25492589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis.
    Xu H; Hazra S; Blanchard JS
    Biochemistry; 2012 Jun; 51(22):4551-7. PubMed ID: 22587688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
    Elings W; Tassoni R; van der Schoot SA; Luu W; Kynast JP; Dai L; Blok AJ; Timmer M; Florea BI; Pannu NS; Ubbink M
    Biochemistry; 2017 Nov; 56(47):6257-6267. PubMed ID: 29087696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G132S Mutation Enhances the Resistance of
    van Alen I; Chikunova A; Safeer AA; Ahmad MUD; Perrakis A; Ubbink M
    Biochemistry; 2021 Jul; 60(28):2236-2245. PubMed ID: 34250791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate.
    Tremblay LW; Hugonnet JE; Blanchard JS
    Biochemistry; 2008 May; 47(19):5312-6. PubMed ID: 18422342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Dubée V; Soroka D; Cortes M; Lefebvre AL; Gutmann L; Hugonnet JE; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2015 May; 59(5):2938-41. PubMed ID: 25733512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis.
    Hazra S; Xu H; Blanchard JS
    Biochemistry; 2014 Jun; 53(22):3671-8. PubMed ID: 24846409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC.
    Iannazzo L; Soroka D; Triboulet S; Fonvielle M; Compain F; Dubée V; Mainardi JL; Hugonnet JE; Braud E; Arthur M; Etheve-Quelquejeu M
    J Med Chem; 2016 Apr; 59(7):3427-38. PubMed ID: 26937999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Lactamase of Mycobacterium tuberculosis Shows Dynamics in the Active Site That Increase upon Inhibitor Binding.
    Elings W; Gaur A; Blok AJ; Timmer M; van Ingen H; Ubbink M
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.